You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
特一藥業(002728.SZ):與海博特簽署《中藥大品種培育戰略合作協議》
格隆匯 07-06 18:58

格隆匯7月6日丨特一藥業(002728.SZ)公吿,為了加強對現有中成藥的傳承和開發,公司於2021年7月5日與廣州海博特醫藥科技有限公司(“海博特”)簽署了《中藥大品種培育戰略合作協議》。

該戰略合作協議旨在以增加產品的適應症及質量和療效的提高為目標,通過臨牀研究或真實世界研究,形成完整的數據資料,提高公司核心品種的專家認知度,利於市場推廣和消費者教育,達到對中成藥的傳承精華守正創新,讓更多的患者受益的同時,推動公司特色中藥品種(含皮膚病血毒丸、止咳寶片、降糖舒丸等)成長為中藥大品種。

同日,特一藥業與海博特就公司皮膚病血毒丸治療痤瘡(青春痘)的多中心臨牀研究達成協議,簽署了《技術服務合同》作為本次戰略合作協議的進展協議。據悉,海博特擬在廣東省內4家醫院開展皮膚病血毒丸治療痤瘡(青春痘)的多中心、前瞻性、單臂自身對照臨牀研究,保證試驗資料完整、真實、準確,及時向特一藥業提供統計報吿及總結報吿。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account